Centene represents a countercyclical investment opportunity in managed care, as it can benefit from economic downturns through increasing enrollment in its Medicaid and individual exchange products.

We are increasing our fair value estimate for HCA to $333 per share from $316, primarily to reflect strong cash flows since our last valuation change and higher 2025 profit prospects as outlined in ...

Discover key takeaways from HCA Healthcare's Q2 2025 earnings call, including strong revenue growth, raised guidance, and strategies to navigate ...

Atul Kherde designed a gadget that provides you with the benefit of walking whilst you sit. It does even more than that.